(Q50972883)

26 March 2018

title

Serum levels of CYFRA 21-1 in nasopharyngeal carcinoma and its possible role in monitoring of therapy (English)

1 reference

26 March 2018

author name string

Ho S

1

1 reference

26 March 2018

Leung WT

2

1 reference

26 March 2018

Yuen J

3

1 reference

26 March 2018

Johnson PJ

4

1 reference

26 March 2018

publication date

1 November 1996

1 reference

26 March 2018

European Journal of Cancer. Part B, Oral Oncology

published in

1 reference

26 March 2018

volume

32B

1 reference

26 March 2018

issue

6

1 reference

26 March 2018

page(s)

377-380

1 reference

26 March 2018

The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0964-1955%2896%2900017-6

7 January 2021

CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0964-1955%2896%2900017-6

7 January 2021

Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1.

1 reference

https://api.crossref.org/works/10.1016%2FS0964-1955%2896%2900017-6

7 January 2021

Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure

1 reference

https://api.crossref.org/works/10.1016%2FS0964-1955%2896%2900017-6

7 January 2021

Epstein-barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0964-1955%2896%2900017-6

7 January 2021

Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0964-1955%2896%2900017-6

7 January 2021

Soluble interleukin-2 receptors in patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0964-1955%2896%2900017-6

7 January 2021

10.1016/S0964-1955(96)00017-6

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018